Activity of Gemifloxacin against Penicillin- and Ciprofloxacin-Resistant Streptococcus pneumoniae Displaying Topoisomerase- and Efflux-Mediated Resistance Mechanisms

AUTOR(ES)

Heaton, Victoria J.

FONTE

American Society for Microbiology

RESUMO

Nine penicillin-resistant Streptococcus pneumoniae clinical isolates from Northern Ireland, resistant to ciprofloxacin (MICs, 2 to 64 μg/ml) through topoisomerase- and/or reserpine-sensitive efflux mechanisms, were highly susceptible to gemifloxacin (MICs, 0.03 to 0.12 μg/ml). Two strains (requiring a ciprofloxacin MIC of 64 μg/ml) carried known quinolone resistance mutations in parC, parE, and gyrB, resulting in S79F, D435V, and E474K changes, respectively. Thus, gemifloxacin is active against clinical strains exhibiting altered topoisomerase and efflux phenotypes.

Documentos Relacionados

• Molecular Epidemiology of Penicillin-Resistant and Ciprofloxacin-Resistant Streptococcus pneumoniae in Canada
• Activities of Newer Fluoroquinolones against Ciprofloxacin-Resistant Streptococcus pneumoniae
• Activity of new quinolones against ciprofloxacin-resistant staphylococci.
• Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus.
• Efflux-Mediated Aminoglycoside and Macrolide Resistance in Burkholderia pseudomallei